Poly(l-lactide)/polycaprolactone based multifunctional coating to deliver paclitaxel/VEGF and control the degradation rate of magnesium alloy stent.

Despite significant advancements made in cardiovascular stents, restenosis, thrombosis, biocompatibility, and clinical complications remain a matter of concern. Herein, we report a biodegradable Mg alloy stent with a dual effect of the drug (Paclitaxel) and growth factor (VEGF) release. To mitigate the fast degradation of Mg alloy, inorganic and organic coatings were formed on the alloy surface. The optimized hierarchal sequence of the coating was the first layer consisting of magnesium fluoride, followed by poly(l-lactide) and hydroxyapatite coating, and finally sealed by a polycaprolactone layer (MgC). PLLA and HAp were used to increase the adhesion strength and biocompatibility of the coating. Paclitaxel and VEGF were loaded in the final PCL layer (Mg-C/PTX-VEGF). As compared to bare Mg alloy (28 % weight loss), our MgC system showed (3.1 % weight loss) successful decrease in the degradation rate. Further, the in vitro biocompatibility illustrated the highly biocompatible nature of our drug and growth factor-loaded system. The in vivo results displayed that the drug loading decreased the inflammation and neointimal hyperplasia as indicated by the α-SMA and CD-68 antibody staining. The growth factor helped in the endothelialization which was established by the FLKI and ICAM antibody staining of the tissue.

In-vivo bone remodeling potential of Sr-d-Ca-P /PLLA-HAp coated biodegradable ZK60 alloy bone plate.

Magnesium and its alloys are widely applied biomaterials due to their biodegradability and biocompatibility. However, rapid degradation and hydrogen gas evolution hinder its applicability on a commercial scale. In this study, we developed an Mg alloy bone plate for bone remodeling and support after a fracture. We further coated the Mg alloy plate with Sr-D-Ca-P (Sr dopped Ca-P coating) and Sr-D-Ca-P/PLLA-HAp to evaluate and compare their biodegradability and biocompatibility in both in vitro and in vivo experiments. Chemical immersion and dip coating were employed for the formation of Sr-D-Ca-P and PLLA-HAp layers, respectively. In vitro evaluation depicted that both coatings delayed the degradation process and exhibited excellent biocompatibility. MC3T3-E1cells proliferation and osteogenic markers expression were also promoted. In vivo results showed that both Sr-D-Ca-P and Sr-D-Ca-P/PLLA-HAp coated bone plates had slower degradation rate as compared to Mg alloy. Remarkable bone remodeling was observed around the Sr-D-Ca-P/PLLA-HAp coated bone plate than bare Mg alloy and Sr-D-Ca-P coated bone plate. These results suggest that Sr-D-Ca-P/PLLA-HAp coated Mg alloy bone plate with lower degradation and enhanced biocompatibility can be applied as an orthopedic implant.

Real-Time Observation of Magnetic Domain Structure Changes with Increasing Temperature for Z-Type Hexagonal Ferrite.

Z-type hexagonal ferrites have recently received attention for their room-temperature magnetoelectric (ME), which is activated when the temperature at which the transverse-conical spin-state transitions to a ferrimagnetic state is increased. The changes in the magnetic domain structure at the transition have been well-documented; however, they are still not understood in detail. In the present study, Lorentz transmission electron microscopy (TEM) analysis combined with an in situ heating experiment was conducted to demonstrate the shift in magnetic domain structure during the transition from the transverse-conical spin arrangement to a ferrimagnetic spin order. The dynamics of the magnetic domain structure changes with the increasing temperature were acquired in real-time. At 490 K, the magnetization transition from the transverse-conical spin state to the ferromagnetic state was demonstrated. Cross-tie domain walls formed during the magnetic transition process. The increased effect of the demagnetizing field applied to the 180° magnetic domains was caused by a lower magnetocrystalline anisotropy (MCA) at the easy axis of magnetization.

Development and properties of duplex MgF2/PCL coatings on biodegradable magnesium alloy for biomedical applications.

The present work addresses the performance of polycaprolactone (PCL) coating on fluoride treated (MgF2) biodegradable ZK60 magnesium alloy (Mg) for biomedical application. MgF2 conversion layer was first produced by immersing Mg alloy substrate in hydrofluoric acid solution. The outer PCL coating was then prepared using dip coating technique. Morphology, elements profile, phase structure, roughness, mechanical properties, invitro corrosion, and biocompatibility of duplex MgF2/PCL coating were then characterized and compared to those of fluoride coated and uncoated Mg samples. The invivo degradation behavior and biocompatibility of duplex MgF2/PCL coating with respect to ZK60 Mg alloy were also studied using rabbit model for 2 weeks. SEM and TEM analysis showed that the duplex coating was uniform and comprised of porous PCL film (~3.3 µm) as upper layer with compact MgF2 (~2.2 µm) as inner layer. No significant change in microhardness was found on duplex coating compared with uncoated ZK60 Mg alloy. The duplex coating showed improved invitro corrosion resistance than single layered MgF2 or uncoated alloy samples. The duplex coating also resulted in better cell viability, cell adhesion, and cell proliferation compared to fluoride coated or uncoated alloy. Preliminary invivo studies indicated that duplex MgF2/PCL coating reduced the degradation rate of ZK60 Mg alloy and exhibited good biocompatibility. These results suggested that duplex MgF2/PCL coating on magnesium alloy might have great potential for orthopedic applications.

A novel fibrous scaffold composed of electrospun porous poly (epsilon-caprolactone) fibers for bone tissue engineering.

In this study, porous poly(ε-caprolactone) (PCL) fiber-based fibrous scaffolds are created using a suitable ratio of dimethyl chloride and acetone by using electrospinning. With the porous structure, it induced CaP particles to easily coat on the fibers after immersion in simulated body fluid solution. The morphology of the electrospun membranes was observed using scanning electron microscopic observation. The results showed that the CaP coated successfully, as examined by scanning electron microscopy, energy-dispersive spectroscopy, X-ray diffraction, transmission electron microscopic techniques and mass comparative analysis. The wettability of the coated fibrous scaffolds was tested using contact angle analysis. The in vitro cellular proliferation and cell interaction with fibrous scaffolds were investigated. In addition, the in vivo bone formation capacity of fibrous scaffolds including the non-porous (PCL-DCM), porous (PCL-DCM/Ace) and CaP coating on PCL/DCM-Ace for 2, 4, 8 and 12 h immersed in SBF solution were also investigated. By measuring the in vitro results, we verified that porous PCL fiber-based fibrous scaffold after 12 h of immersion in simulated body fluid (PCL-DCM/Ace-12) was excellent for cell interaction, growth and proliferation. The in vivo analyses showed that the PCL-DCM/Ace-12 fibrous scaffold enabled greater acceleration of bone formation than PCL/DCM and PCL/DCM-Ace fibrous scaffolds.